Financial Performance - Total revenue for 2025 was CNY 180,910.78 million, a decrease of 10.07% compared to CNY 201,162.03 million in the previous year[3] - Operating profit fell to CNY 11,040.45 million, down 64.96% from CNY 31,508.70 million year-on-year[3] - Net profit attributable to shareholders was CNY 2,401.90 million, a significant decline of 92.03% from CNY 30,153.36 million in the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 8,206.26 million, down 71.44% from CNY 28,733.33 million[3] - Basic earnings per share decreased to CNY 0.04, a drop of 92.45% compared to CNY 0.53 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were CNY 429,309.23 million, a decrease of 2.76% from CNY 441,509.30 million[4] - Equity attributable to shareholders was CNY 269,796.66 million, down 2.14% from CNY 275,707.57 million[4] Market Conditions and Impairments - The decline in revenue and profit was primarily due to reduced domestic market demand and industry policy impacts[5] - The company recognized impairment losses on various assets based on prudence principles as of December 31, 2025[5] Audit and Reporting - The financial data presented is preliminary and subject to change upon final audit in the 2025 annual report[6]

Financial Performance - Total revenue for 2025 was RMB 926.31 million, a decrease of 32.54% compared to RMB 1,373.19 million in the previous year[3] - Net loss attributable to shareholders was RMB 499.01 million, an increase of 217.52% from RMB 157.16 million in the previous year[5] - Equity attributable to shareholders decreased by 24.47% to RMB 1.22 billion from RMB 1.61 billion at the beginning of the period[3] - The company's asset-liability ratio increased by 7.2 percentage points to 60.76%[5] Asset and Investment - Total assets at the end of the reporting period were RMB 3.19 billion, down 12.37% from RMB 3.64 billion at the beginning of the period[5] - R&D investment for 2025 increased by approximately RMB 62 million compared to the previous year, focusing on embodied intelligence[7] Business Challenges - Revenue from the overseas system integration business declined by approximately 55.1% due to challenges in the European automotive industry[6] - The gross margin for the industrial robot business decreased by approximately 6.7 percentage points compared to the previous year, leading to a phase loss in this segment[6] - The company is undergoing impairment testing for goodwill and customer relationships in its overseas system integration business due to significant losses[6] Government Support - Government subsidies recognized in profit and loss for 2025 decreased by approximately RMB 83.5 million compared to the previous year[8]

Financial Performance - The company achieved total operating revenue of RMB 81,273.36 million, representing a year-on-year increase of 52.50%[5] - The net profit attributable to shareholders of the parent company was a loss of RMB 16,069.72 million, with a year-on-year increase in losses[5] - The weighted average return on net assets was -13.76%, an increase in losses by 4.34 percentage points compared to the previous year[5] - Total assets at the end of the reporting period were RMB 297,143.46 million, while equity attributable to shareholders of the parent company was RMB 108,269.72 million[5] - The net asset per share attributable to shareholders of the parent company decreased to RMB 4.09, down 13.71% from the previous year[4] Product Development and Market Expansion - The company successfully launched Jikaxitini tablets and expanded market coverage, contributing to revenue growth[5] - Recombinant human thrombin was officially included in the national medical insurance catalog, leading to a significant increase in sales[5] - R&D expenses increased year-on-year due to the varying stages of new drug development projects[5] - The company plans to continue its efforts in new drug research and market expansion[5] Financial Data and Risk Disclosure - The company emphasizes the preliminary nature of the financial data, which has not been audited, and warns investors of potential risks[7][8]

特别提示： 证券代码：002063 证券简称：远光软件 公告编号：2026-005 远光软件股份有限公司 2025 年度业绩快报 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 本公告所载 2025 年度的财务数据仅为初步核算数据，未经会计师事务所审计，与年度报告中披露 的最终数据可能存在差异，请投资者注意投资风险。 一、2025 年度主要财务数据和指标 四、业绩泄漏原因和股价异动情况分析（如适用） 不适用。 单位：万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度 | | --- | --- | --- | --- | | 营业总收入 | 259,322.20 | 239,839.33 | 8.12% | | 营业利润 | 32,103.92 | 31,738.58 | 1.15% | | 利润总额 | 31,976.02 | 31,694.50 | 0.89% | | 归属于上市公司股东的净利润 | 30,110.33 | 29,291.53 | 2.80% | | 扣除非经常性损益后的归属于上 市公司股东的净利润 | 30,081.99 | 2 ...

Financial Performance - The total operating revenue for 2025 was RMB 141,902.81 million, a year-on-year increase of 1.72%[4] - The net profit attributable to shareholders of the parent company was RMB 14,380.88 million, a decrease of 22.17% compared to the previous year[4] - The net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was RMB 13,071.81 million, down 25.07% year-on-year[4] - The basic earnings per share decreased to RMB 1.20, down 21.94% from RMB 1.54 in the previous year[4] - The weighted average return on net assets decreased by 2.52 percentage points to 7.24%[4] Assets and Equity - The total assets at the end of the reporting period were RMB 359,492.75 million, an increase of 8.90% from the beginning of the period[6] - The equity attributable to shareholders of the parent company was RMB 202,522.40 million, up 3.86% from the beginning of the period[6] Profitability and Strategy - The company's gross profit margin improved by 0.6 percentage points during the reporting period[6] - The company faced significant pressure on traditional product prices, impacting overall profitability[7] - The company implemented strategies to optimize profit structure through the release of high-margin new products[6]

Financial Performance - The total operating revenue for 2025 reached RMB 2,658,702,301.63, representing a year-on-year increase of 58.37%[4] - The net profit attributable to the parent company was a loss of RMB 716,578,794.49, compared to a loss of RMB 603,372,915.33 in the previous year[4] - The basic earnings per share were -1.60 RMB, down from -1.35 RMB in the previous year[4] - The weighted average return on net assets decreased by 14.21 percentage points to -39.68%[4] Assets and Equity - Total assets at the end of the reporting period were RMB 5,317,430,882.31, an increase of 26.48% from the beginning of the period[4] - The equity attributable to the parent company decreased by 24.71% to RMB 1,556,715,677.80[4] Market Expansion and Investments - The company expanded its market share through acquisitions, including Xiamen Jiebert Semiconductor Co., Nanjing Tianyi Hexin Electronics Co., and Hangzhou Lingxin Microelectronics Co.[7] - Research and development expenses increased significantly due to ongoing investments in innovation and market expansion[8] Government Support and Impairment Testing - The company recognized government subsidies that positively impacted the net profit attributable to the parent company, excluding non-recurring gains and losses[8] - The company is currently conducting asset impairment tests, which may affect the final net profit figures[8]

Financial Performance - Total revenue for 2025 reached CNY 486.13 million, an increase of 18.41% compared to CNY 410.56 million in the previous year[3] - Net profit attributable to shareholders of the parent company was CNY 88.13 million, up 13.18% from CNY 77.87 million year-on-year[3] - The company achieved a basic earnings per share of CNY 1.47, a decrease of 20.97% from CNY 1.86 in the previous year[3] - The weighted average return on equity was 11.27%, down 0.78 percentage points from 12.05%[3] Assets and Equity - Total assets at the end of the reporting period amounted to CNY 1,866.44 million, reflecting a growth of 128.32% from CNY 817.46 million at the beginning of the period[5] - Shareholders' equity attributable to the parent company increased to CNY 1,765.91 million, a rise of 143.53% from CNY 725.12 million[5] - The net asset per share attributable to the parent company rose by 82.55% to CNY 22.07 from CNY 12.09[8] - The increase in total assets was primarily due to the issuance of new shares during the reporting period[7] Market Growth and Opportunities - The growth in revenue was driven by increased demand in the access network sector, particularly due to domestic operators' FTTR construction and gigabit optical network upgrades[6] - The introduction and certification of 25Gbps-100Gbps chip products have opened new growth opportunities in the high-end market[6]

Financial Performance - Total operating revenue for 2025 reached RMB 63,006.65 million, a year-on-year increase of 24.89% compared to RMB 50,451.05 million in the previous year[3] - Operating profit decreased to RMB -4,095.02 million, a decline of 767.51% from RMB 613.48 million in the previous year[3] - Net profit attributable to shareholders of the parent company was RMB -2,212.24 million, down 284.29% from RMB 1,200.41 million in the previous year[3] - Basic earnings per share fell to RMB -0.11, a decrease of 283.33% compared to RMB 0.06 in the previous year[3] Assets and Equity - Total assets increased by 8.94% to RMB 351,162.90 million from RMB 322,356.43 million at the beginning of the period[3] - Shareholders' equity attributable to the parent company decreased by 4.27% to RMB 210,819.93 million from RMB 220,220.58 million at the beginning of the period[3] Innovation and Management - The company accelerated innovation with increased R&D spending on key projects such as artificial synthetic high-purity quartz sand and solid oxide fuel cells[6] - Management expenses increased significantly due to ongoing management reforms and the implementation of a new employee stock ownership plan[6] - The company experienced a substantial decline in operating profit and net profit due to the low base effect from the previous year[6] Report Accuracy - There are no significant uncertainties affecting the accuracy of the performance report[7]

Financial Performance - Total operating revenue for 2025 was RMB 998.15 million, a decrease of 8.79% compared to the previous year[3] - Operating profit was RMB -65.05 million, down 118.67% year-over-year[3] - Total profit amounted to RMB -63.13 million, reflecting a decline of 118.05% from the prior year[3] - Net profit attributable to shareholders of the parent company was RMB -24.20 million, a decrease of 107.44% compared to the previous year[3] - Basic earnings per share were RMB -0.06, down 107.79% year-over-year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 5,021.61 million, a decrease of 2.79% from the beginning of the period[3] - Shareholders' equity attributable to the parent company was RMB 3,758.96 million, down 5.53% from the beginning of the period[3] Performance Decline Factors - The decline in performance was primarily due to the implementation of centralized procurement policies, leading to reduced product prices and profits[6] Investment Gains - The company recognized a fair value change gain of RMB 173 million from its investment in Zhejiang Tongyuan Kang Pharmaceutical Co., Ltd., which was listed on the Hong Kong Stock Exchange during the reporting period[7] Financial Data Disclaimer - The company cautions investors that the financial data presented is preliminary and subject to final audit[10]

Financial Performance - Total revenue for 2025 reached CNY 2,736,594.00 million, a year-on-year increase of 53.81%[3] - Net profit attributable to shareholders of the parent company was CNY 73,485.50 million, a decrease of 59.44% compared to the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 47,231.20 million, down 70.38% year-on-year[3] - Basic earnings per share decreased to CNY 0.6062, a decline of 59.78% from the previous year[3] Assets and Equity - Total assets at the end of the reporting period were CNY 4,554,418.00 million, reflecting a growth of 10.00% from the beginning of the period[4] - Shareholders' equity attributable to the parent company increased to CNY 1,386,349.80 million, up 1.02% from the start of the period[4] Market Performance - The company achieved significant growth in domestic wind turbine sales capacity and market share, alongside substantial growth in overseas sales and new orders[5] - The decline in profit levels was primarily due to increased competition and falling bidding prices in the domestic onshore wind turbine market[8] Cost Management - The company successfully controlled costs, achieving better cost reduction targets for main products and a significant decrease in expense ratios[5] Financial Caution - The company warns that the financial data presented is preliminary and subject to change upon final audit, urging investors to be aware of investment risks[9]